SCHEMBL1723002

SCHEMBL1723002

CC(C)Cn1cc(-c2ccc(N3CCC(CCNC(=O)O)CC3)nc2)cn1

nearest known ligand 0.43

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
RET P07949 5/20 0.43
CHRM4 P08173 9/20 0.42
NAMPT P43490 1/20 0.42
DGAT1 O75907 2/20 0.41
CHRM2 P08172 3/20 0.39
CHRM1 P11229 3/20 0.39
CHRM5 P08912 2/20 0.39
CHRM3 P20309 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14796867 0.86 RET (0.48) RETCHRM4DGAT1
SCHEMBL14796986 0.84 PIM1 (0.46) CHRM4NAMPT
SCHEMBL2405573 0.82 CHRM4 (0.36) RETCHRM4NAMPT
SCHEMBL1728738 0.79 CHRM4 (0.50) CHRM4DGAT1CHRM2CHRM1
SCHEMBL1711018 0.79 CHRM4 (0.57) CHRM4DGAT1CHRM2CHRM1
SCHEMBL1728880 0.78 CHRM4 (0.49) CHRM4CHRM2CHRM1CHRM5CHRM3
SCHEMBL14796962 0.78 CHRM4 (0.51) RETCHRM4DGAT1CHRM2CHRM1
SCHEMBL1728839 0.78 CHRM4 (0.52) CHRM4CHRM2CHRM1CHRM5CHRM3
SCHEMBL14796952 0.77 CHRM4 (0.45) CHRM4DGAT1CHRM2CHRM1CHRM5
SCHEMBL1711102 0.77 CHRM4 (0.59) CHRM4DGAT1CHRM2CHRM1CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2344486-B1 ALKYLTHIAZOL CARBAMATE DERIVATIVES, PREPARATION THEREOF AND THEIR USE AS FAAH INHIBITORS SANOFI SA (FR) 2013-03-27 EP disclosed
EP-2344486-A2 ALKYLTHIAZOL CARBAMATE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF Sanofi-Aventis (FR) 2011-07-20 EP disclosed
WO-2010010288-A2 ALKYLTHIAZOL CARBAMATE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2010-01-28 WO disclosed